Mango Intake and Gut and Cardiometabolic Health in Hispanic/Latino Adolescents
The Influence of Mango-Derived Intestinal Microbial Metabolites on Gut Permeability, Inflammation, and Cardiometabolic Health Markers in Hispanic/Latino Adolescents
1 other identifier
interventional
25
1 country
1
Brief Summary
Mangos contain a number of nutrients that may improve gut and metabolic health. The purpose of this research is to see how eating mangos every day for 4 weeks instead of snacks high in calories and low in nutrients such as cookies, crackers, chips, and candy can impact adolescent health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2025
CompletedFirst Posted
Study publicly available on registry
August 15, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2028
February 3, 2026
January 1, 2026
2.5 years
July 7, 2025
January 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Microvascular Function
Microvascular function as measured by peripheral arterial tonometry (ENDO PAT 2000)
4 weeks
Secondary Outcomes (9)
Cytokines
4 weeks
short chain fatty acids
4 weeks
Bile acids
4 weeks
zonulin
4 weeks
soluble lipopolysaccharide binding protein
4 weeks
- +4 more secondary outcomes
Study Arms (2)
Mango arm
EXPERIMENTALAtaulfo Mango intake
No mango intake
NO INTERVENTION4 weeks of no mango intake
Interventions
Eligibility Criteria
You may qualify if:
- \- Male or Female 12-19 years old
- BMI ≥ 85th percentile (https://www.bcm.edu/bodycomplab/BMIapp/BMI-calculator-kids.html)
- Self-reported Hispanic/Latino
- Subject is willing and able to comply with the study protocols
- Subject is willing to consume the test products
- Female-specific criteria: if menstruating, eumenorrheic (regular monthly menstrual cycles of 25-30-days in length)
- Access to a smartphone or tablet at least 1x / day and willing to take pictures associated with the products to be consumed in the study
You may not qualify if:
- \- Reported food allergies.
- Currently taking prescription drugs, with the exception of asthma inhalers, which are allowed
- BMI \<85th percentile (https://www.bcm.edu/bodycomplab/BMIapp/BMI-calculator-kids.html)
- Current participation in a moderate or high-intensity daily exercise routine
- Self-reported disease, serious illness, or who are currently under acute medical care.
- Currently taking prescription drugs.
- Any supplement use, including multi-vitamin/ mineral, herbal, plant or botanical, fish oil, and oil supplements, and not willing to discontinue before starting the study.
- Vegetarian or vegan diet
- Self-reported malabsorption or gastrointestinal issues
- Fruit and vegetable intake exceeding daily recommendations of 5 servings
- Smoking (vaping, conventional nicotine-containing products or marijuana)
- Current enrollee in a clinical research study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Academic Surge; Ragle Human Nutrition Research Center
Davis, California, 95616, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roberta R Holt, PhD
University of California, Davis
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2025
First Posted
August 15, 2025
Study Start
October 1, 2025
Primary Completion (Estimated)
March 31, 2028
Study Completion (Estimated)
March 31, 2028
Last Updated
February 3, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share